NDC 0169-2001

Insulin Diluting Medium for NovoLog

Water Injection

Insulin Diluting Medium for NovoLog is a Intravenous; Subcutaneous Injection, Solution in the Human Prescription Drug category. It is labeled and distributed by Novo Nordisk. The primary component is Water.

Product ID0169-2001_1c6ad27d-ee7c-4581-b6d8-976993f189c1
NDC0169-2001
Product TypeHuman Prescription Drug
Proprietary NameInsulin Diluting Medium for NovoLog
Generic NameWater Injection
Dosage FormInjection, Solution
Route of AdministrationINTRAVENOUS; SUBCUTANEOUS
Marketing Start Date2001-08-27
Marketing CategoryNDA / NDA
Application NumberNDA020986
Labeler NameNovo Nordisk
Substance NameWATER
Active Ingredient Strength1 mL/mL
NDC Exclude FlagN
Listing Certified Through2020-12-31

Packaging

NDC 0169-2001-90

1 VIAL, GLASS in 1 CARTON (0169-2001-90) > 10 mL in 1 VIAL, GLASS
Marketing Start Date2018-08-01
NDC Exclude FlagN
Sample Package?N

NDC SPL Data Element Entries

NDC 0169-2001-90 [00169200190]

Insulin Diluting Medium for NovoLog INJECTION, SOLUTION
Marketing CategoryNDA
Application NumberNDA020986
Product TypeHUMAN PRESCRIPTION DRUG
Marketing Start Date2018-08-01

Drug Details

Active Ingredients

IngredientStrength
WATER1 mL/mL

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.